Mineralys Therapeutics, Inc. MLYS Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Mineralys Therapeutics, Inc. (MLYS) reported accretion (amortization) of discounts and premiums, investments of $4.63M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Mineralys Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments increased by 342.2% year-over-year, from $1.05M to $4.63M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 147.8% compound annual growth rate (CAGR), from $649K to $9.88M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to net income resulting from the amortization of premiums or the accretion of discounts on held-to-maturity or available-for-sale investment securities. It reflects the gradual recognition of interest income over the life of the investment to align the carrying value with the effective interest rate. Investors use this to reconcile reported net income with actual cash flows generated from investment portfolios.